Abstract

96 Prospective evaluation of galactomannan enzyme immunoassay (GM-EIA) and (1–3) B-D-Glucan (BG) for the diagnosis of invasive fungal infections in patients with hematological malignancy

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call